Infectious Diseases News and Research

RSS

Shorter, effective treatment for latent TB infection

Research, led by Timothy Sterling, M.D., professor of Medicine at Vanderbilt University Medical Center, has led to an important change in CDC recommendations in the regimen for prevention of the centuries-old scourge, tuberculosis (TB).

9 Dec 2011

Nighttime-lights imagery can pinpoint disease hotspots

Normally used to spot where people live, satellite images of nighttime lights can help keep tabs on the diseases festering among them, too, according to new research.

9 Dec 2011

ISARIC aims to prepare clinical research community for next influenza pandemic

An international consortium aimed at ensuring that the clinical research community is better prepared for the next influenza pandemic or other rapidly emerging public health threat is launched today by leading funders of medical research from across the globe.

8 Dec 2011

Aethlon receives approval to begin Hemopurifier study at Sarcoma Oncology Center

Aethlon Medical, Inc., the pioneer in developing therapeutic filtration devices to address infectious disease and cancer, announced today that a cancer research study to test the ex vivo effectiveness of the Aethlon Hemopurifier to capture tumor-secreted exosomes from the blood of advanced-stage cancer patients has received institutional review board approval to begin studies at the Sarcoma Oncology Center, based in Santa Monica, California.

7 Dec 2011

Headache affects one of every two HIV/AIDS patients

A University of Mississippi study of headaches among HIV patients is being hailed as a critical step to improving treatment and reducing unnecessary medical costs among sufferers.

7 Dec 2011

Fake, poor-quality drugs boosting malaria drug resistance in Southeast Asia, U.S. experts say

"Fake or poor quality malaria drugs are boosting resistance in parts of southeast Asia, a problem that is likely to worsen unless tighter regulations are adopted, U.S. experts said Monday" at a hearing of the House Foreign Affairs Subcommittee on Africa, Global Health, and Human Rights, Agence France-Presse reports.

7 Dec 2011

Researchers discover new tick-borne infection

Researchers at the University of Gothenburg's Sahlgrenska Academy have discovered a brand new tick-borne infection. Since the discovery, eight cases have been described around the world, three of them in the Gothenburg area, Sweden.

7 Dec 2011

Special 'ribbon cutting' event of new Rush University Medical Center on Dec. 8, 2011

Leading Chicago area government officials and other dignitaries will join Rush University Medical Center trustees, leadership, doctors and nurses on Thursday, Dec. 8 at 11 a.m. for a special "ribbon cutting" event, signifying the completion of the new hospital building at Ashland Avenue and the Eisenhower Expressway. Attendees will also receive a tour of key components of the new hospital.

6 Dec 2011

Advancing the development of a malaria transmission-blocking vaccine

Three leaders in malaria vaccine development announced today a collaboration to evaluate a potential vaccine candidate designed to prevent transmission of malaria from mosquitoes to humans—a type of vaccine that researchers think could contribute to the eventual eradication of malaria.

6 Dec 2011

Social determinants contribute to incidence of H1N1 virus in U.S. Hispanics during 2009 pandemic

Social determinants, including the lack of paid sick leave, contributed to higher risk of exposure to the influenza A (H1N1) virus among Hispanics in the U.S. during the 2009 H1N1 pandemic, according to a study led by Sandra Crouse Quinn, professor of family science and senior associate director of the Maryland Center for Health Equity at the University of Maryland School of Public Health.

6 Dec 2011

Women for Positive Action comments on research into prevention strategies for sexual transmission of HIV

To mark World AIDS Day (December 1, 2011), Women for Positive Action has released a commentary which discusses recent and ongoing research on prevention strategies for the sexual transmission of HIV. With expert opinion from Teresa Branco, Margaret Johnson, Karine Lacombe, Anne-Mette Lebech, Mona Loutfy, Angelina Namiba, Maria Jesús Pérez Elías and Sharon Walmsley, the article is focused on the potential clinical relevance of these studies.

3 Dec 2011

Bristol-Myers Squibb, Tibotec partner for TMC435 Phase II combination study in HCV

Medivir AB, the research-based speciality pharmaceutical company focused on the development of high-value treatments for infectious diseases, announces that its development partner, Tibotec Pharmaceuticals, has entered into an agreement with Bristol-Myers Squibb Company.

2 Dec 2011

CCEI offers trial course on recognizing infectious diseases in the early childhood setting

ChildCare Education Institute (CCEI), an IACET approved, nationally accredited, distance training institution dedicated exclusively to the child care and education workforce, offers new users the trial course CCEI114B: Recognizing Infectious Diseases in the Early Childhood Setting at no cost in December.

2 Dec 2011

NIAID director Fauci discusses moving forward in AIDS fight

In this interview with GlobalPost's John Donnelly, Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases at NIH, discusses "his perspective of the fight against AIDS at this moment, and how discoveries by scientists can now be best used."

1 Dec 2011

Researchers identify first gene associated with frequent herpes-related cold sores

A team of researchers from the University of Utah and the University of Massachusetts has identified the first gene associated with frequent herpes-related cold sores.

1 Dec 2011

Oral ingestion of apple polyphenols can prevent colitis in mice

Here's another reason why "an apple a day keeps the doctor away"-according to new research findings published in the Journal of Leukocyte Biology, oral ingestion of apple polyphenols can suppress T cell activation to prevent colitis in mice.

1 Dec 2011

FDA clears Abbott's new ARCHITECT 25-OH Vitamin D assay

Abbott announced today it has received clearance from the U.S. Food and Drug Administration for a fully-automated 25-OH Vitamin D assay performed on its widely used ARCHITECT laboratory testing platform.

30 Nov 2011

DNA gyrase B could rapidly eliminate TB, shorten treatment time

In research at SRI International, scientists evaluating new drug targets against tuberculosis (TB) recently validated the preclinical effectiveness of a target that could rapidly eliminate infections and potentially shorten treatment time. The new drug target is a protein called DNA gyrase B, found in bacteria that cause TB infections.

30 Nov 2011

Nanomedicine breakthrough by IBN and IBM named a ‘world changer’

A nanoparticle that can destroy drug-resistant bacteria developed by the Institute of Bioengineering and Nanotechnology (IBN), and the IBM Almaden Research Center, has recently been named one of 10 world changing ideas by Scientific American in its Technology Special Report ('World Changing Ideas – 10 New Technologies That Will Make a Difference', December 2011).

29 Nov 2011

Shots reduce risk of chicken pox

Infants below the age of one may be too young to get the chicken pox vaccine but far fewer of them got the itchy rash after the U.S. started routinely vaccinating older children in 1995, according to a new study.

29 Nov 2011

Infectious Diseases News and Research

Shorter, effective treatment for latent TB infection

Nighttime-lights imagery can pinpoint disease hotspots

ISARIC aims to prepare clinical research community for next influenza pandemic

Aethlon receives approval to begin Hemopurifier study at Sarcoma Oncology Center

Headache affects one of every two HIV/AIDS patients

Fake, poor-quality drugs boosting malaria drug resistance in Southeast Asia, U.S. experts say

Researchers discover new tick-borne infection

Special 'ribbon cutting' event of new Rush University Medical Center on Dec. 8, 2011

Advancing the development of a malaria transmission-blocking vaccine

Social determinants contribute to incidence of H1N1 virus in U.S. Hispanics during 2009 pandemic

Women for Positive Action comments on research into prevention strategies for sexual transmission of HIV

Bristol-Myers Squibb, Tibotec partner for TMC435 Phase II combination study in HCV

CCEI offers trial course on recognizing infectious diseases in the early childhood setting

NIAID director Fauci discusses moving forward in AIDS fight

Researchers identify first gene associated with frequent herpes-related cold sores

Oral ingestion of apple polyphenols can prevent colitis in mice

FDA clears Abbott's new ARCHITECT 25-OH Vitamin D assay

DNA gyrase B could rapidly eliminate TB, shorten treatment time

Nanomedicine breakthrough by IBN and IBM named a ‘world changer’

Shots reduce risk of chicken pox

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News